International Journal of High Risk Behaviors and Addiction
Crossref
1. Machine Learning Study: From the Toxicity Studies to Tetrahydrocannabinol Effects on Parkinson's Disease
- Mehmet Ali Yucel
- Ibrahim Ozcelik
- Oztekin Algul
2.
3. Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET
- Daniel Gündel
- Winnie Deuther-Conrad
- Lea Ueberham
- Sarandeep Kaur
- Elina Otikova
- Rodrigo Teodoro
- Magali Toussaint
- Thu Hang Lai
- Oliver Clauß
- Matthias Scheunemann
- Guy Bormans
- Michael Bachmann
- Klaus Kopka
- Peter Brust
- Rareş-Petru Moldovan
4. Interplay between the Glymphatic System and the Endocannabinoid System: Implications for Brain Health and Disease
- Juan F. Osuna-Ramos
- Josué Camberos-Barraza
- Laura E. Torres-Mondragón
- Ángel R. Rábago-Monzón
- Alejandro Camacho-Zamora
- Marco A. Valdez-Flores
- Carla E. Angulo-Rojo
- Alma M. Guadrón-Llanos
- Verónica J. Picos-Cárdenas
- Loranda Calderón-Zamora
- Javier A. Magaña-Gómez
- Claudia D. Norzagaray-Valenzuela
- Feliznando I. Cárdenas-Torres
- Alberto K. De la Herrán-Arita
5. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
- Qi-Wen Han
- Yu-He Yuan
- Nai-Hong Chen
6. Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?
- V. F. Kitchigina
7. Mechanistic insights into the protective effect of paracetamol against rotenone-induced Parkinson’s disease in rats: Possible role of endocannabinoid system modulation
- Aya Yassin Labib
- Ramy M. Ammar
- Reem N. El-Naga
- Alshaymaa Amin Zaki El-Bahy
- Mariane G. Tadros
- Haidy E. Michel
8. Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists
- Mojgan Aghazadeh Tabrizi
- Pier Giovanni Baraldi
- Pier Andrea Borea
- Katia Varani
9. Polyunsaturated fatty acids and endocannabinoids in health and disease
- Hércules Rezende Freitas
- Alinny Rosendo Isaac
- Renato Malcher-Lopes
- Bruno Lourenço Diaz
- Isis Hara Trevenzoli
- Ricardo Augusto De Melo Reis
10. Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
- Rui S. Rodrigues
- Diogo M. Lourenço
- Sara L. Paulo
- Joana M. Mateus
- Miguel F. Ferreira
- Francisco M. Mouro
- João B. Moreira
- Filipa F. Ribeiro
- Ana M. Sebastião
- Sara Xapelli
11. Development of [18F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain
- Rodrigo Teodoro
- Daniel Gündel
- Winnie Deuther-Conrad
- Lea Ueberham
- Magali Toussaint
- Guy Bormans
- Peter Brust
- Rareş-Petru Moldovan
12. Distant neuroinflammation acutely induced by focal brain injury and its control by endocannabinoid system
- Anna A. Karan
- Yulia S. Spivak
- Elena M. Suleymanova
- Konstantin A. Gerasimov
- Alex P. Bolshakov
- Lyudmila V. Vinogradova
13. Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis
- Rui S. Rodrigues
- Filipa F. Ribeiro
- Filipa Ferreira
- Sandra H. Vaz
- Ana M. Sebastião
- Sara Xapelli
14. Cannabinoids and the expanded endocannabinoid system in neurological disorders
- Luigia Cristino
- Tiziana Bisogno
- Vincenzo Di Marzo
15. Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington’s disease
- Shiraz Tyebji
- Anthony J. Hannan
16.
17. Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
- Carlotta Granchi
- Flavio Rizzolio
- Stefano Palazzolo
- Sara Carmignani
- Marco Macchia
- Giuseppe Saccomanni
- Clementina Manera
- Adriano Martinelli
- Filippo Minutolo
- Tiziano Tuccinardi
18. Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
- Tommaso Cassano
- Silvio Calcagnini
- Lorenzo Pace
- Federico De Marco
- Adele Romano
- Silvana Gaetani
19.
20.
21. Potential Neuroprotective Effect of Cannabinoids in COVID-19 Patients
- José Luis Cortes-Altamirano
- Ariadna Yáñez-Pizaña
- Samuel Reyes-Long
- González-Maciel Angélica
- Cindy Bandala
- Herlinda Bonilla-Jaime
- Alfonso Alfaro-Rodríguez
22. Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
- Fabio Arturo Iannotti
- Vincenzo Di Marzo
- Stefania Petrosino
23. Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
- Barbara Vuic
- Tina Milos
- Lucija Tudor
- Marcela Konjevod
- Matea Nikolac Perkovic
- Maja Jazvinscak Jembrek
- Gordana Nedic Erjavec
- Dubravka Svob Strac
24. Novel Psychoactive Substances in Young Adults with and without Psychiatric Comorbidities
- Giovanni Martinotti
- Matteo Lupi
- Tiziano Acciavatti
- Eduardo Cinosi
- Rita Santacroce
- Maria Salvina Signorelli
- Laura Bandini
- Giulia Lisi
- Diego Quattrone
- Paola Ciambrone
- Andrea Aguglia
- Federica Pinna
- Salvatore Calò
- Luigi Janiri
- Massimo di Giannantonio
25. Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
- Elaine C. D. Gonçalves
- Gabriela M. Baldasso
- Maíra A. Bicca
- Rodrigo S. Paes
- Raffaele Capasso
- Rafael C. Dutra
26. Molecular Targets of Cannabidiol in Neurological Disorders
- Clementino Ibeas Bih
- Tong Chen
- Alistair V.W. Nunn
- Michaël Bazelot
- Mark Dallas
- Benjamin J. Whalley
27. Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH)
- Mojgan Aghazadeh Tabrizi
- Pier Giovanni Baraldi
- Emanuela Ruggiero
- Giulia Saponaro
- Stefania Baraldi
- Romeo Romagnoli
- Adriano Martinelli
- Tiziano Tuccinardi
28. Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis
- Richard S. Bedlack
- Nanette Joyce
- Gregory T. Carter
- Sabrina Paganoni
- Chafic Karam
29.
30.
31. Cannabidiol and Other Cannabinoids in Demyelinating Diseases
- Carmen Navarrete
- Adela García-Martín
- Alain Rolland
- Jim DeMesa
- Eduardo Muñoz
32. Potential Therapeutic Targets of the Endocannabinoid System in Common Neurodegenerative Disorders and Organic Acidemias
- Gabriela Aguilera
- Abel Santamaria
33. Methamphetamine administration impairs behavior, memory and underlying signaling pathways in the hippocampus
- Sakineh Alizadeh Golsorkhdan
- Mahdi Eskandarian Boroujeni
- Abbas Aliaghaei
- Mohammad Amin Abdollahifar
- Afshar Ramezanpour
- Reza Nejatbakhsh
- Iraj Jafari Anarkooli
- Elahe Barfi
- Mohammad Javad Fridoni
34.
35.